Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydralazine and Valproate with Neoadjuvant Chemo in Breast Cancer
NCT00395655Phase 2Terminated
- Sponsor
- Instituto Nacional de Cancerología
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hydralazine and magnesium valproate in breast cancer, sponsored by Instituto Nacional de Cancerología. Primary endpoints: Global DNA methylation, Histone Deacetylase Activity and 1 more. Started Jun 2005; status: terminated.
02
Drugs
hydralazinemagnesium valproate
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00395655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395655.